Associated Retinal Consultants, PC

Grand Rapids, Michigan 49564

0 studies enrolling now · 8 studies all time

What they study most

Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, Macular Edema, Panuveitis, Retinal Vein Occlusion, Uveitis, Anterior, Uveitis, Intermediate, Uveitis, Posterior

Studies at this site

• An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD — Completed
• A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration — Completed
• Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration — Completed
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO — Stopped early
• Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy — Completed
• A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis — Completed
• A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis — Completed
• A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis — Completed